Cavion Collaborators Present Data At American Association for Cancer Research

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Cavion LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors and neurologic diseases, announced today that its University of Virginia collaborators Barbara Dziegielewska, Ph.D., and Jaroslaw Dziegielewski, Ph.D., will present data at the Annual Meeting of the American Association for Cancer Research (AACR), the premier cancer research event being held in Philadelphia, Pennsylvania, from April 18-22.

Help employers find you! Check out all the jobs and post your resume.